Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Elucidating the Immune Response of Participants Undergoing Milk Oral Immunotherapy
FY 2017-18
Summary
Food allergens are common triggers of anaphylaxis that account for up to 50% of all anaphylaxis cases. Cow's milk allergy (CMA) is the most common food allergy in children and there is no cure. The only treatment for CMA is strict avoidance. However, milk is ubiquitous in Western diets. Therefore, a more effective therapy is required to treat CMA. The Mazer laboratory initiated the first Canadian randomized-controlled trial of milk oral immunotherapy (OIT). This trial aims to allow children with CMA to consume cow's milk without adverse allergic responses. From the trial, we will investigate how the immune system of children with CMA changes during OIT. We will focus on regulatory B cells (Breg), a subset of white blood cells that are responsible for regulation of the immune inflammation. Bregs exposed to interleukin-10 induce other B cells to produce immunoglobulins (Ig) such as IgA and IgG4. These Igs may serve as blocking antibodies to IgE, which activates cells that trigger allergic responses. The exact roles of these Igs and Bregs in allergic responses remain poorly understood. Using enzyme-linked immunosorbent assays and flow cytometry, we will track the Igs and Bregs throughout the OIT to elucidate function. The results from this project will provide a better understanding the role of Bregs. This is crucial for insight into converting allergic responses against allergens into tolerance and developing better therapies for food allergy.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
386545
Name
Zhao Wei
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the Immune Response of Participants Undergoing Milk Oral Immunotherapy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anaphylaxis; Child Allergy; Cow'S Milk Allergy; Desensitization; Food Allergy; Oral Immunotherapy; Sustained Tolerance
Abstract
Food allergens are common triggers of anaphylaxis that account for up to 50% of all anaphylaxis cases. Cow's milk allergy (CMA) is the most common food allergy in children and there is no cure. The only treatment for CMA is strict avoidance. However, milk is ubiquitous in Western diets. Therefore, a more effective therapy is required to treat CMA. The Mazer laboratory initiated the first Canadian randomized-controlled trial of milk oral immunotherapy (OIT). This trial aims to allow children with CMA to consume cow's milk without adverse allergic responses. From the trial, we will investigate how the immune system of children with CMA changes during OIT. We will focus on regulatory B cells (Breg), a subset of white blood cells that are responsible for regulation of the immune inflammation. Bregs exposed to interleukin-10 induce other B cells to produce immunoglobulins (Ig) such as IgA and IgG4. These Igs may serve as blocking antibodies to IgE, which activates cells that trigger allergic responses. The exact roles of these Igs and Bregs in allergic responses remain poorly understood. Using enzyme-linked immunosorbent assays and flow cytometry, we will track the Igs and Bregs throughout the OIT to elucidate function. The results from this project will provide a better understanding the role of Bregs. This is crucial for insight into converting allergic responses against allergens into tolerance and developing better therapies for food allergy.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhao, Wei
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~